To Evaluate the Efficacy and Safety of the Transfemoral Mitral Valve Repair System in the Treatment of Patients With Moderately Severe and Severe Functional Mitral Regurgitation(FMR) Who Remained Clinically Symptomatic After Guideline-directed Medical Treatment

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.

Also called NCT05508438

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Pan Xiangbin (from the registry)
Registry
  • NCT NCT05508438
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT05508438. Allocation not applicable; no masking; primary purpose treatment. Start 2022-08-30 (anticipated); primary completion 2023-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
To Evaluate the Efficacy and Safety of the Transfemoral Mitral Valve Repair System in the Treatment of Patients With Moderately Severe and Severe Functional Mitral Regurgitation(FMR) Who Remained Clinically Symptomatic After Guideline-directed Medical Treatment
Condition
Mitral Valve Insufficiency
Intervention (Device)
Transfemoral mitral-valve repair
Lead sponsor
Pan Xiangbin (class: other)

Record details

Record id
cardio:ct-nct05508438
Content hash
e5b2a5609aaaa5533fd72d9a889e6f92410ff538f1b3ed132ffa9ad2c31765ee